Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof Angela Russell has been named as a ‘Rising Star’ in the BioBeat 50 Movers and Shakers in BioBusiness 2016 report.

Released annually, the report celebrates 50 outstanding women entrepreneurs and business leaders who are recognised for their contributions to global health innovation.  BioBeat’s founder Miranda Weston-Smith said that the report highlights those women who are “transforming today’s challenges into tomorrow’s opportunities” and are inspirational “pioneers who are setting the pace in laboratories, healthcare, entrepreneurial companies …“ among others. 

Angela Russell, Associate Professor of Medicinal Chemistry at the Departments of Chemistry and Pharmacology at the University of Oxford and co-founder of OxStem Ltd said “I am delighted to have been recognised in this report standing alongside some exceptional bioscience business leaders in the field.  Our research at OxStem has the potential to impact on the healthcare of millions worldwide with the approach of developing small molecule drugs in a wide range of therapeutic areas including cancer, neurodegenerative diseases and heart failure.  I hope that my nomination, together with the women featured in this report, helps to inspire the next generation of bioscience entrepreneurs”.

BioBeat 50 Movers and Shakers in BioBusiness 2016 report

Angela Russell, Associate Professor of Medicinal Chemistry, University of Oxford and Co-founder OxStem. Launched in May 2016, Angela co-founded OxStem, a revolutionary University of Oxford spin-out company focussed on regenerative medicine. OxStem aims to identify new classes of drugs that can reprogram or stimulate existing resident cells to repair tissues in age-related conditions including cancer, neurodegenerative diseases and heart failure. The company has raised £16.9 million this year, a record for a UK spin-out, to fund the development of a series of daughter companies.

In her academic career, with over 15 years medicinal chemistry experience, Angela has published over 80 original articles, book chapters and patent applications and co-founded the Oxford spin-out MuOx Ltd, acquired by Summit Therapeutics plc in 2013.

Similar stories

Student Prizes for Biomedical Sciences and Medicine 2021-2022

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2021-2022 academic year.

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Researchers discover novel form of adaptation in the auditory system

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have found that the auditory system adapts to the changing acoustics of reverberant environments by temporally shifting the inhibitory tuning of cortical neurons to remove reverberation.

20 minutes of daily exercise can keep teens' doctors away

Teenagers should exercise vigorously for at least 20 minutes per day to reap increased cardiorespiratory fitness (CRF), according to a cross-sectional study from the UK led by University of Oxford researchers.